Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$11.34 - $21.46 $4.06 Million - $7.68 Million
-358,082 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.88 - $21.42 $1.39 Million - $7.67 Million
358,082 New
358,082 $7.26 Million
Q4 2017

Feb 14, 2018

SELL
$4.53 - $7.09 $2.06 Million - $3.23 Million
-455,656 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$5.71 - $6.9 $2.6 Million - $3.14 Million
455,656
455,656 $2.86 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.28B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Crawford Lake Capital Management, LLC Portfolio

Follow Crawford Lake Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.